Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1976 20
1977 65
1978 46
1979 45
1980 64
1981 99
1982 99
1983 115
1984 92
1985 122
1986 118
1987 176
1988 176
1989 171
1990 137
1991 115
1992 107
1993 95
1994 78
1995 138
1996 195
1997 194
1998 177
1999 125
2000 107
2001 88
2002 97
2003 97
2004 77
2005 105
2006 90
2007 77
2008 75
2009 84
2010 78
2011 65
2012 61
2013 66
2014 71
2015 64
2016 64
2017 64
2018 50
2019 17
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

4,161 results
Results by year
Filters applied: . Clear all
Page 1
Histamine H2-receptor antagonists for urticaria.
Fedorowicz Z, et al. Cochrane Database Syst Rev 2012 - Review. PMID 22419335
There is lack of agreement on the efficacy of H2-receptor antagonists used in the treatment of urticaria. OBJECTIVES: To assess the safety and effectiveness of H2-receptor antagonists in the treatment of urticaria. ...Thus, at present, the review does not allow confident decision-making about the use of H2-receptor antagonists for urticaria. ...
There is lack of agreement on the efficacy of H2-receptor antagonists used in the treatment of urticaria. OBJECTIVES: To asses …
What are the differences between the H2-receptor antagonists?
Schunack W. Aliment Pharmacol Ther 1987 - Review. PMID 2908767
Cimetidine, ranitidine and famotidine are competitive antagonists, while the long-acting H2-receptor antagonists, e.g. loxtidine and lamitidine, are insurmountable H2-receptor blockers. ...The overall number of side-effects of the H2-receptor antagonists is in the range of 2-3% and no irreversible adverse effects are known. ...
Cimetidine, ranitidine and famotidine are competitive antagonists, while the long-acting H2-receptor antagonists, e.g. …
Histamine H2 Receptor Antagonists, Left Ventricular Morphology, and Heart Failure Risk: The MESA Study.
Leary PJ, et al. J Am Coll Cardiol 2016 - Clinical Trial. PMID 27150686 Free PMC article.
BACKGROUND: Myocardial H2 receptor activation may promote cardiac fibrosis and apoptosis in pre-clinical models and histamine H2 receptor antagonist (H2RA) use may improve symptoms in participants with heart failure (HF); however, relationships between H2RA use, incident HF, and longitudinal change in left ventricular (LV) morphology are not known. ...These associations suggest histamine signaling may be important in the pathogenesis of HF. (Multi-Ethnic Study of Atherosclerosis [MESA]; NCT00005487)....
BACKGROUND: Myocardial H2 receptor activation may promote cardiac fibrosis and apoptosis in pre-clinical models and histamine
Optimizing the Use of Medications and Other Therapies in Infant Gastroesophageal Reflux
Ciciora SL and Woodley FW. Paediatr Drugs 2018 - Review. PMID 30198060
Our review of the literature has revealed a paucity of data regarding the use of histamine-2 receptor antagonists and proton pump inhibitors in infants. ...
Our review of the literature has revealed a paucity of data regarding the use of histamine-2 receptor antagonists and proton p …
Histamine H2-receptor antagonists.
Feldman M and Richardson CT. Adv Intern Med 1978 - Review. PMID 24327
Development of histamine H2-receptor antagonists has enhanced the understanding of histamine physiology and pharmacology. The effect of H2-receptor antagonists on gastrointestinal physiology has been studied extensively. ...Assuming that toxic effects do not develop, H2-receptor antagonists should improve the treatment of acid-peptic disease....
Development of histamine H2-receptor antagonists has enhanced the understanding of histamine physiology and phar …
H2-antagonists and alcohol. Do they interact?
Gugler R. Drug Saf 1994 - Review. PMID 7912509
There are conflicting data on the existence of significant first-pass metabolism of alcohol (ethanol) in the human stomach and its inhibition by histamine H2-receptor antagonists. ...In this case, when first-pass metabolism of alcohol does not exist, this by definition cannot be abolished by H2-antagonists. ...
There are conflicting data on the existence of significant first-pass metabolism of alcohol (ethanol) in the human stomach and its inhibitio …
H2-receptor antagonists.
Ivey KJ. Int J Dermatol 1980 - Review. PMID 6105135
Development of a Validated Comparative Stability-Indicating Assay Method for Some H2-Receptor Antagonists.
Ahmed S, et al. J Chromatogr Sci 2017. PMID 28486578
A comparative force degradation high performance thin layer chromatography (HPTLC) method was developed and validated for some H2-receptor antagonists. The studied H2-receptor antagonists were ranitidine (RAN), nizatidine (NIZ) and famotidine (FAM). The degradation behaviors of the studied H2-receptor antagonists were studied under different stress conditions (hydrolytic, thermal and oxidative) conditions as well as storage conditions according to International Conference on Harmonization (ICH) recommendations. ...
A comparative force degradation high performance thin layer chromatography (HPTLC) method was developed and validated for some H2-rec …
4,161 results
Jump to page
Feedback